Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04878107
Status:
UNKNOWN
Last Update Posted:
2022-05-02
First Post:
2021-05-04
Brief Title:
SBRTLDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1L1 Inhibitor and Chemotherapy
Sponsor:
Wuhan University
Organization:
Wuhan University